Energenesis Biomedical CO.,LTD. (TPE:6657)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
33.45
+3.00 (9.85%)
Sep 8, 2026, 1:30 PM CST

TPE:6657 Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-298.61-258.4-231.08-260.38-265.66-120.24
Depreciation & Amortization
17.4122.5522.7623.7824.3522.85
Other Amortization
00.020.050.050.060.06
Loss (Gain) From Sale of Assets
0.030.01-0.22--
Stock-Based Compensation
13.0617.5614.8514.8711.094.92
Other Operating Activities
-0.36-0.63-0.72-1.04-0.010.46
Change in Accounts Receivable
-0.05-0.540.080.61-0.790.31
Change in Inventory
-0.11-0.160.04-0.150.16-0.02
Change in Accounts Payable
-0.190.08-0.03-0.030.070.02
Change in Unearned Revenue
-2.79-2.68-0.93---0.04
Change in Other Net Operating Assets
41.17-0.2214.28-2.97-2.12-5.6
Operating Cash Flow
-200.23-222.41-180.71-225.05-232.84-97.29
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-3.08-2.31-0.75-0.84-6.45-8.9
Sale (Purchase) of Intangibles
-0.02-0.02---0.14-
Investment in Securities
38095.47192.11-58.11182-107
Other Investing Activities
-0.22-1.321.87-00.13
Investing Cash Flow
376.6891.83193.23-58.96175.42-115.76

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
--6.07-6.2-6.52-6.51-6.79
Lease Payments
-6.14-6.07-6.2-6.52-6.51-6.79
Net Debt Issued (Repaid)
-6.14-6.07-6.2-6.52-6.51-6.79
Issuance of Common Stock
1.94434.29151.49446.944.75294.65
Repurchase of Common Stock
-39.59-28.89----
Other Financing Activities
-----0.13
Financing Cash Flow
-43.79399.34145.29440.42-1.75287.98

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.33-0.160.09---
Net Cash Flow
132.99268.6157.9156.41-59.1874.94

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-203.31-224.72-181.47-225.89-239.29-106.18
Free Cash Flow Growth
------
Free Cash Flow Margin
-2661.10%-2928.30%-2341.79%-3155.81%-3255.16%-1417.84%
Free Cash Flow Per Share
-2.30-2.54-2.38-3.14-3.59-1.77
Levered Free Cash Flow
-131.09-131.5-110.26-129.83-148.4-57.24
Unlevered Free Cash Flow
-130.79-131.21-110.13-129.69-148.27-57.06
Free Cash Flow After Leases
-209.45-230.78-187.67-232.41-245.79-112.97

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
0.470.460.210.210.210.28
Cash Income Tax Paid
0.630.630.850.53-0.09-0.06
Change in Working Capital
68.25-3.5113.43-2.55-2.67-5.33